Long-Term Outcomes of the Boston Type I Keratoprosthesis in the Management of Corneal Limbal Stem Cell Deficiency

Published January 1, 2016 | Version v1

Journal article Open

1. Univ Calif Los Angeles, David Geffen Sch Med, Stein Eye Inst, Los Angeles, CA 90095 USA

Purpose: To report the long-term outcomes of the Boston type I keratoprosthesis (KPro) in the management of limbal stem cell deficiency (LSCD).

Files

Name	Size	Download all
bib-9bf7e961-a3b7-4c40-abdd-7ba947dd14c0.txt md5:8ba1977a59992843d09c5c7f3c909d99	194 Bytes	Preview Download

All versions

This version

Views

Downloads

Data volume

3.7 kB

Details

Created

March 16, 2021

Resource type

Journal article

Published in

CORNEA, 35(9), 1156-1164, 2016.

Rights

Creative Commons Attribution 4.0 International

The Creative Commons Attribution license allows re-distribution and re-use of a licensed work on the condition that the creator is appropriately credited. Read more